Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$335,679
+$20,891 QoQ
Shares Held
15,708
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#137
of 196 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARISTEIA CAPITAL, L.L.C. holds $20,591,629 across 15 Biotechnology names. NAMS ranks #4 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
37,250 | $11,774,352 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
64,475 | $7,548,088 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
53,650 | $933,510 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
15,708 | $335,679 | |
| 5 | OSRH |
OSR Health, Inc.
|
73,341 | $0 | |
| 6 | MLEC |
Moolec Science SA
|
330,014 | $0 | |
| 7 | ASBP |
Aspire Biopharma Holdings, Inc.
|
681,516 | $0 | |
| 8 | OABIW |
OmniAb, Inc.
|
679,919 | $0 |
All Filings in NAMS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 NAMSW | $335,679 | 15,708 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 NAMSW | $314,788 | 15,708 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 NAMSW | $361,284 | 15,708 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||